Description: Trametinib / GSK1120212 specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine/tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.
| Catalog | OFC871700173 |
| CAS | 871700-17-3 |
| Category | Fluorinated APIs |
| Synonyms | GSK1120212 |
| Purity | >98% |
※ Please kindly note that our products are for research use only.
| IUPAC Name | N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide |
| InChI | InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34) |
| InChI Key | LIRYPHYGHXZJBZ-UHFFFAOYSA-N |
| Isomeric SMILES | CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5 |
| EC Number | 629-899-3 |
| Molecular Formula | C26H23FIN5O4 |
| Molecular Weight | 615.39 |
| Appearance | White to off-white solid powder |
| XLogP3-AA | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 615.07788 g/mol |
| Monoisotopic Mass | 615.07788 g/mol |
| Topological Polar Surface Area | 102Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1090 |
Please kindly note that our products and services are for research use only.